This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Express Scripts
ESRX : NASDAQ : Health Care

$71.68 0.75 | 1.06%
Today's Range: 70.92 - 71.94
Avg. Daily Volume: 5,443,600
04/24/14 - 2:11 PM ET

Financial Analysis


EXPRESS SCRIPTS HOLDING CO's gross profit margin for the fourth quarter of its fiscal year 2013 is essentially unchanged when compared to the same period a year ago. Sales and net income have dropped, although the growth in revenues underperformed the average competitor within the industry, the net income growth did not. EXPRESS SCRIPTS HOLDING CO has very weak liquidity. Currently, the Quick Ratio is 0.46 which clearly shows a lack of ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.

During the same period, stockholders' equity ("net worth") has decreased by 6.61% from the same quarter last year. The key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY13 Q4 FY12
Net Sales ($mil)25809.927393.6
EBITDA ($mil)1692.91654.6
EBIT ($mil)1069.91053.2
Net Income ($mil)501.9504.1


Balance Sheet Q4 FY13 Q4 FY12
Cash & Equiv. ($mil)2014.22813.5
Total Assets ($mil)53548.258111.2
Total Debt ($mil)13947.015915.0
Equity ($mil)21837.423385.0


Profitability Q4 FY13 Q4 FY12
Gross Profit Margin8.68.67
EBITDA Margin6.556.04
Operating Margin4.153.84
Sales Turnover1.951.61
Return on Assets3.442.25
Return on Equity8.695.75
Debt Q4 FY13 Q4 FY12
Current Ratio0.640.82
Debt/Capital0.390.41
Interest Expense125.7157.4
Interest Coverage8.516.69


Share Data Q4 FY13 Q4 FY12
Shares outstanding (mil)773.6818.1
Div / share0.00.0
EPS0.640.62
Book value / share28.2328.58
Institutional Own % n/a n/a
Avg Daily Volume5333666.04730003.0

Valuation


BUY. This stock's P/E ratio indicates a premium compared to an average of 31.65 for the Health Care Providers & Services industry and a significant premium compared to the S&P 500 average of 18.59. To use another comparison, its price-to-book ratio of 2.59 indicates valuation on par with the S&P 500 average of 2.56 and a discount versus the industry average of 2.92. The current price-to-sales ratio is well below the S&P 500 average and is also below the industry average, indicating a discount.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ESRX 31.68 Peers 31.65   ESRX 11.87 Peers 29.21

Average. An average P/E ratio can signify an industry neutral price for a stock and an average growth expectation.

ESRX is trading at a valuation on par with its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ESRX is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ESRX 13.06 Peers 18.27   ESRX 0.28 Peers 4.56

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

ESRX is trading at a discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ESRX trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ESRX 2.59 Peers 2.92   ESRX 24.86 Peers 194.12

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ESRX is trading at a discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, ESRX is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ESRX 0.54 Peers 0.75   ESRX 11.06 Peers 11.70

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ESRX is trading at a significant discount to its industry on this measurement.

 

Average. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.

ESRX is keeping pace with its peers on the basis of sales growth.

 

 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs